IL53013A0 - 1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them - Google Patents

1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them

Info

Publication number
IL53013A0
IL53013A0 IL53013A IL5301377A IL53013A0 IL 53013 A0 IL53013 A0 IL 53013A0 IL 53013 A IL53013 A IL 53013A IL 5301377 A IL5301377 A IL 5301377A IL 53013 A0 IL53013 A0 IL 53013A0
Authority
IL
Israel
Prior art keywords
heterocyclyloxypropane
hydroxy
derivatives
amino
production
Prior art date
Application number
IL53013A
Other versions
IL53013A (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL53013A0 publication Critical patent/IL53013A0/en
Publication of IL53013A publication Critical patent/IL53013A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL53013A 1976-10-05 1977-09-28 1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them IL53013A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1263576A CH607585A5 (en) 1976-10-05 1976-10-05 Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine

Publications (2)

Publication Number Publication Date
IL53013A0 true IL53013A0 (en) 1977-11-30
IL53013A IL53013A (en) 1981-09-13

Family

ID=4384944

Family Applications (1)

Application Number Title Priority Date Filing Date
IL53013A IL53013A (en) 1976-10-05 1977-09-28 1-phehethylamino-2-hydroxy-3-pyridyloxy-(or pyrazinyloxy) propanes,their production and pharmaceutical compositions containing them

Country Status (21)

Country Link
JP (1) JPS5350177A (en)
AT (1) AT358037B (en)
AU (1) AU514676B2 (en)
BE (1) BE858867A (en)
CA (1) CA1105021A (en)
CH (1) CH607585A5 (en)
DE (1) DE2740678A1 (en)
DK (1) DK402877A (en)
ES (1) ES462389A1 (en)
FI (1) FI772681A (en)
FR (1) FR2367065A1 (en)
GB (1) GB1591723A (en)
GR (1) GR71677B (en)
IE (1) IE45692B1 (en)
IL (1) IL53013A (en)
NL (1) NL7710394A (en)
NO (1) NO773125L (en)
NZ (1) NZ185267A (en)
PT (1) PT67048B (en)
SE (1) SE7710250L (en)
ZA (1) ZA775698B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
DK267779A (en) * 1978-06-27 1979-12-28 Merck & Co Inc PROCEDURE FOR THE PREPARATION OF N-ARALKYLAMINO-PROPOXYCYANOPYRIDINES
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
ES2038180T3 (en) * 1986-06-30 1993-07-16 Asahi Kasei Kogyo Kabushiki Kaisha A PROCEDURE FOR PREPARING A COMPOUND THAT IS A DERIVATIVE OF PIRAZINE.
WO2001036412A1 (en) * 1999-11-15 2001-05-25 Eli Lilly And Company Process for the preparation of aryloxy propanolamines

Also Published As

Publication number Publication date
FR2367065A1 (en) 1978-05-05
AU514676B2 (en) 1981-02-19
NO773125L (en) 1978-04-06
PT67048A (en) 1977-10-01
DK402877A (en) 1978-04-06
FR2367065B1 (en) 1980-10-10
GR71677B (en) 1983-06-21
ATA648777A (en) 1980-01-15
CH607585A5 (en) 1978-09-15
ES462389A1 (en) 1978-07-01
IE45692B1 (en) 1982-10-20
BE858867A (en) 1978-03-20
JPS5350177A (en) 1978-05-08
DE2740678A1 (en) 1978-04-06
SE7710250L (en) 1978-04-06
PT67048B (en) 1979-02-16
FI772681A (en) 1978-04-06
GB1591723A (en) 1981-06-24
AT358037B (en) 1980-08-11
IE45692L (en) 1978-04-05
ZA775698B (en) 1978-05-30
CA1105021A (en) 1981-07-14
IL53013A (en) 1981-09-13
NZ185267A (en) 1979-07-11
AU2912577A (en) 1979-04-05
NL7710394A (en) 1978-04-07

Similar Documents

Publication Publication Date Title
IL53533A0 (en) Novel tetralin derivatives their production and pharmaceutical compositions containing them
IL51840A0 (en) Trans-hexahydro-pyrido-indoles their production and pharmaceutical compositions containing them
IL52858A0 (en) New derivatives of perhydro-aza-heterocycles their production and pharmaceutical compositions containing them
IL52337A0 (en) Novel dipeptide derivatives their manufacture and pharmaceutical compositions containing them
IL52493A0 (en) 5-aroyl-pyrrolopyrrole-1-carboxylic acid derivatives their production and pharmaceutical compositions containing them
IL51966A0 (en) Novel aminopiperidines their production and pharmaceutical compositions incorporating them
IL51360A0 (en) New polypeptide derivatives their production and pharmaceutical compositions containing them
IL52517A0 (en) New isoxazole derivatives their production and pharmaceutical compositions containing them
IL51812A0 (en) New isothiazolopyridine derivatives their preparation and pharmaceutical compositions containing them
IL52307A0 (en) Novel dipeptide derivatives their manufacture and pharmaceutical compositions containing them
IL53332A0 (en) Morphanthridine derivatives their production and pharmaceutical compositions containing them
IL51334A0 (en) Novel pyrrolidine derivatives their production and pharmaceutical compositions containing them
IL51426A0 (en) Novel derivatives of tetrahydroechinocandin b their production and pharmaceutical compositions containing them
GB2032423B (en) N - phenyl-indoline derivatives their production and pharmaceutical compositions containing them
IL51456A0 (en) New piperazine derivatives their production and pharmaceutical compositions containing them
IL54105A (en) 2-acylamino-4-amino-5-benzylpyrimidine derivatives,their production and pharmaceutical compositions containing them
IL53013A0 (en) 1-amino-2-hydroxy-3-heterocyclyloxypropane derivatives their production and pharmaceutical compositions containing them
IL53642A0 (en) New indoloquinolizine derivatives their preparation and pharmaceutical compositions containing them
IL52006A0 (en) Novel nephthalene derivatives their preparation and pharmaceutical compositions containing them
IL53009A0 (en) New imidazoisoquinoline derivatives their preparation and pharmaceutical compositions containing them
JPS5394028A (en) Pharmaceutical composition and production thereof
IL51194A0 (en) Novel ergoline derivatives their production and pharmaceutical compositions containing them
IL53120A0 (en) Novel quinoline derivatives their production and pharmaceutical compositions containing them
IL50198A0 (en) New morphanthridine derivatives their production and pharmaceutical compositions containing them
IL52962A0 (en) New perhydroindolinol derivatives their preparation and pharmaceutical compositions containing them